Medical Journals

Nuclear Export of Retinoid X Receptor Alpha in Response to Interleukin-1beta-mediated Cell Signaling: Roles for Jnk and Ser260.

Authors:
  • Zimmerman Tracy L
  • Thevananther Sundararajah
  • Ghose Romi
  • Burns Alan R
  • Karpen Saul J

From: Texas Children’s Liver Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.

The Journal of biological chemistry

  • Publish Date: Jun 2006
  • ISSN: 0021-9258
  • Volume: 281
  • Issue: 22
  • Pages: 15434-40
  • Medium: Print
  • Language: English
  • Citation (JAMA): Zimmerman Tracy L, Thevananther Sundararajah, Ghose Romi, et al. Nuclear Export of Retinoid X Receptor Alpha in Response to Interleukin-1beta-mediated Cell Signaling: Roles for Jnk and Ser260.. J. Biol. Chem. Jun 2006;281:15434-40

Abstract

As the obligate heterodimer partner to class II nuclear receptors, the retinoid X receptor alpha (RXRalpha) plays a vital physiological role in the regulation of multiple hepatic functions, including bile formation, intermediary metabolism, and endobiotic/xenobiotic detoxification. Many RXRalpha-regulated genes are themselves suppressed in inflamed liver via unknown mechanisms, which constitute a substantial component of the negative hepatic acute phase response. In this study we show that RXRalpha, generally considered a stable nuclear resident protein, undergoes rapid nuclear export in response to signals initiated by the pro-inflammatory cytokine interleukin-1beta (IL-1beta), a central activator of the acute phase response. Within 30 min of exposure to IL-1beta, nuclear levels of RXRalpha are markedly suppressed in human liver-derived HepG2 cells, temporally coinciding with its appearance in the cytoplasm. The nuclear residence of RXRalpha is maintained by inhibiting c-jun N-terminal kinase (JNK, curcumin or SP600125) or CRM-1-mediated nuclear export (Leptomycin B). Pretreatment with the proteasome inhibitor MG132 blocks IL-1beta-mediated reductions in nuclear RXRalpha levels while increasing accumulation in the cytoplasm. Mutational studies identify one residue, serine 260, a JNK phosphoacceptor site whose phosphorylation status had an unknown role in RXRalpha function, as critical for IL-1beta-mediated nuclear export of transfected human RXRalpha-green fluorescent fusion constructs. These findings indicate that inflammation-mediated cell signaling leads to rapid and profound reductions in nuclear RXRalpha levels, via a multistep, JNK-dependent mechanism involving Ser260, nuclear export, and proteasomal degradation. Thus, inflammation-meditated cell signaling targets RXRalpha for nuclear export and degradation; a potential mechanism that explains the broad suppression of RXRalpha-dependent gene expression in the inflamed liver.

Mesh Headings (Keywords): Active Transport, Cell Nucleus, Amino Acid Substitution, Base Sequence, Binding Sites, Cell Line, DNA, Humans, Interleukin-1, JNK Mitogen-Activated Protein Kinases, Models, Biological, Mutagenesis, Site-Directed, Recombinant Fusion Proteins, Retinoid X Receptor alpha, Serine, Signal Transduction, Transfection


Check for Full Text / PubMed Unique Identifier (PMID): 16551633


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.